Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't

Autor: Stuart Rich, Robert Schilz

Publikováno v: Advances in Pulmonary Hypertension. 15:184-189

Calcium channel blocker (CCB) therapy continues to be an element of modern pulmonary arterial hypertension treatment guidelines. However, the true number of patients that can be effectively treated with CCBs is very small. It is important to remember

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c3bbe4db90cbed8b34443f9a3065483
https://doi.org/10.21693/1933-088x-15.4.184

A Case of suspected Sick Sinus Syndrome due to combined Beta-blocker and Calcium Channel Blocker Therapy: Anesthesia Management

Autor: Sourav Mahajan, Naina P Dalvi, Sunil Gvalani, Sunil K Gvalani, Apeksha A Gala

Publikováno v: Journal of Research & Innovation in Anesthesia. 2:68-70

Sick sinus syndrome (SSS) is a generalized abnormality of cardiac impulse formation. Abnormalities encompassed by this syndrome may include inappropriate sinus bradycardia, sinus arrest, bradyarrhythmias, or tachyarrhythmias. We present a case of a 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f7f276d831e01b7d09961aa69909866
https://doi.org/10.5005/jp-journals-10049-0036

Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry

Autor: Douwes, Johannes M, Humpl, Tilman, Bonnet, Damien, Beghetti, Maurice, Ivy, D Dunbar, Berger, Rolf M F

Publikováno v: Journal of the American College of Cardiology, 67(11), 1312-1323. ELSEVIER SCIENCE INC
Journal of the American College of Cardiology, Vol. 67, No 11 (2016) pp. 1312-23

BACKGROUND In pulmonary arterial hypertension (PAH), acute vasodilator response testing (AVT) is considered important to identify adult patients with favorable prognosis using calcium-channel blocker (CCB) therapy. However, in pediatric PAH, criteria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ef0096a26d5de61f9d7b88704a685593
https://research.rug.nl/en/publications/127bd938-fe52-4d5d-bab6-61efee55afd0

PULMONARY VASOREACTIVITY TESTING WITH ADENOSINE PREDICTS LONG TERM HEMODYNAMIC RESPONSE TO PROSTACYCLIN MONOTHERAPY, AND PROSTACYCLIN AND PHOSPHODIESTERASE-5 INHIBITOR COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION

Autor: Jonathan D. Rich, Ramsey M. Wehbe, Stuart Rich

Publikováno v: Journal of the American College of Cardiology. 71:A1951

Pulmonary vasoreactivity testing (PVT) with low dose adenosine predicts the clinical response to calcium channel blocker therapy in patients with pulmonary arterial hypertension (PAH). While higher dose adenosine PVT predicts the hemodynamic response

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ae57acebc5350edc421787b0ce96da1
https://doi.org/10.1016/s0735-1097(18)32492-6

Adherence to Calcium Channel Blocker Therapy in Older Adults: A Comparison of Amlodipine and Felodipine

Autor: Arocho R, J. Menzin, MH Tran, William J. Elliott, Lang K, M. Friedman, L Boulanger

Publikováno v: Journal of International Medical Research. 32:233-239

The efficacy of dihydropyridine calcium channel blockers for treating hypertension appears to be similar, but a variety of factors, including patient characteristics, tolerability and pharmacokinetic properties, may influence treatment adherence and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebfcac7b8520a58cdc665436ff2c11ea
https://doi.org/10.1177/147323000403200301